Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
filingDate |
2018-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b05abbf4c8360f1d24d6fbbc47dc544 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a82352dfcffc3685c9ba17a9bd14892 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4e19677667c99069b958e8686a1760c |
publicationDate |
2019-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-3074813-A1 |
titleOfInvention |
Imidazolidine compounds |
abstract |
The present invention provides a compound of Formula (I) wherein X is selected from the group consisting of (CH2)2- and CH2-CH(CH3)-; Q is selected from the group consisting of C(CH3)2 and Formula (a); or a pharmaceutically acceptable salt thereof; compositions, methods to treat liver disease and NASH. |
priorityDate |
2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |